IP Verse

Antibody Which Is Directed Against Galectin 9 And Is An Inhibitor Of The Suppressor Activity Of Regulatory T Lymphocytes - EP3152234

PATENT ANALYSIS

Patent Details

Grant Date
Jun 26, 2024
Company
CELLVAX
Oppositions

HOFFMANN EITLE

More patents of Cellvax

EP3152234

Want to monitor this patent?

Feel free to send us a message here and we will get back to you